Article

Positive outlook critical in interaction among patients with glaucoma

When treating patients with glaucoma, ophthalmologists need to remember that the message they convey through their verbal communication plays a critical role in patient care, said Reay H. Brown, MD.

When treating patients with glaucoma, ophthalmologists need to remember that the message theyconvey through their verbal communication plays a critical role in patient care, said Reay H.Brown, MD.

"Glaucoma is a bad disease and patients are worried about blindness," said Dr. Brown, ASCRSglaucoma clinical committee chairman, and a private practitioner in Atlanta. "The facts, however, are that treatment is usually successful, most patients maintain vision,and even if the treatment is only partially effective, glaucoma damage develops veryslowly.

"Therefore, in caring for glaucoma patients, treating IOP is not enough," he added. "Our goalis to break the patients' fear cycle and leave them with hope."

Since physicians control the conversation about a patient's condition, they can extend either apositive or negative attitude. Dr. Brown said many opportunities exist to highlightsuccess.

Because stability is the goal of treatment, clinicians can emphasize a stable IOP, visualfield, or imaging results, he said. A favorable IOP response to new medical therapy or surgicalintervention represents another chance to underscore success.

On the other side of the coin, Dr. Brown said that there are statements to avoid, such as"Nothing is working," "I've tried everything," "I don't know what else to do," or "I giveup."

"These are all thoughts we may have from time to time," he said. "However, keep in mind that wenever run out of therapy. There is always something else we can do, and if a treatment is notworking, don't take it personally. Referring the patient is a net that you always have beneathyou."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.